Pages that link to "Q51659721"
Jump to navigation
Jump to search
The following pages link to LAGRAN program for area and moments in pharmacokinetic analysis. (Q51659721):
Displaying 50 items.
- Application of computer-assisted radiotelemetry in the pharmacokinetic and pharmacodynamic modeling of procainamide and N-acetylprocainamide (Q28287818) (← links)
- Antiretroviral Activity, Biochemistry, and Pharmacokinetics of 3'-Azido-2',3'-Dideoxy-5-Methylcytidine (Q28323745) (← links)
- In vitro cytotoxicity, pharmacokinetics, tissue distribution, and metabolism of small-molecule protein kinase D inhibitors, kb-NB142-70 and kb-NB165-09, in mice bearing human cancer xenografts (Q30414963) (← links)
- Efficacy, pharmacokinetics, tisssue distribution, and metabolism of the Myc-Max disruptor, 10058-F4 [Z,E]-5-[4-ethylbenzylidine]-2-thioxothiazolidin-4-one, in mice (Q33338530) (← links)
- Phase I pharmacokinetic and pharmacodynamic study of 17-dimethylaminoethylamino-17-demethoxygeldanamycin, an inhibitor of heat-shock protein 90, in patients with advanced solid tumors (Q33388351) (← links)
- Phase I study of vorinostat in patients with advanced solid tumors and hepatic dysfunction: a National Cancer Institute Organ Dysfunction Working Group study (Q33391851) (← links)
- A phase I trial and pharmacokinetic evaluation of CI-980 in patients with advanced solid tumors (Q33500970) (← links)
- Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers. (Q33691292) (← links)
- Relationship between didanosine exposure and surrogate marker response in human immunodeficiency virus-infected outpatients (Q33692547) (← links)
- Dose-dependent pharmacokinetics of mezlocillin in rats (Q33742036) (← links)
- Ceftriaxone disposition in open-heart surgery patients (Q33742082) (← links)
- Pharmacokinetics of 2',3'-dideoxyinosine in monkeys (Q33744728) (← links)
- Pharmacokinetics and metabolism of racemic 2',3'-dideoxy-5-fluoro-3'-thiacytidine in rhesus monkeys (Q33745246) (← links)
- Pharmacokinetics of meropenem in patients with intra-abdominal infections (Q33747920) (← links)
- Pharmacokinetics of antiviral polyoxometalates in rats (Q33750885) (← links)
- Impact of dosing schedule upon suppression of a retrovirus in a murine model of AIDS encephalopathy (Q33751841) (← links)
- Quantitative relationships between zidovudine exposure and efficacy and toxicity (Q33756402) (← links)
- Evaluation of several dosing regimens of cefepime, with various simulations of renal function, against clinical isolates of Pseudomonas aeruginosa in a pharmacodynamic infection model (Q33975896) (← links)
- Tolerance and pharmacokinetic interactions of rifabutin and azithromycin (Q33982133) (← links)
- A phase I, pharmacokinetic, and pharmacodynamic study of two schedules of vorinostat in combination with 5-fluorouracil and leucovorin in patients with refractory solid tumors (Q34099365) (← links)
- In Vitro Cytotoxicity and In Vivo Efficacy, Pharmacokinetics, and Metabolism of 10074-G5, a Novel Small-Molecule Inhibitor of c-Myc/Max Dimerization (Q34359903) (← links)
- Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics (Q34392654) (← links)
- Pharmacokinetics and pharmacodynamic modeling of direct suppression effects of methylprednisolone on serum cortisol and blood histamine in human subjects (Q34392723) (← links)
- Bioelectrical impedance modelling of gentamicin pharmacokinetic parameters (Q34397940) (← links)
- Effect of the immunomodulator tilorone on the in vivo acetylation of procainamide in the rat. (Q34661389) (← links)
- Pharmacokinetics of (-)-2'-3'-dideoxy-3'-thiacytidine in woodchucks (Q35123010) (← links)
- Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections (Q35123123) (← links)
- Comparison of conventional dosing versus continuous-infusion vancomycin therapy for patients with suspected or documented gram-positive infections (Q35123139) (← links)
- Pharmacodynamics of once- or twice-daily levofloxacin versus vancomycin, with or without rifampin, against Staphylococcus aureus in an in vitro model with infected platelet-fibrin clots. (Q35123155) (← links)
- Pharmacokinetics of a water-soluble fullerene in rats (Q35127705) (← links)
- Pharmacokinetics of (-)-beta-D-2-aminopurine dioxolane and (-)-beta-D-2-amino-6-chloropurine dioxolane and their antiviral metabolite (-)-beta-D-dioxolane guanine in rhesus monkeys (Q35128085) (← links)
- Prenatal and postpartum pharmacokinetics of stavudine (2',3'-didehydro-3'-deoxythymidine) and didanosine (dideoxyinosine) in pigtailed macaques (Macaca nemestrina) (Q35128529) (← links)
- Pharmacodynamics of RP 59500 (quinupristin-dalfopristin) administered by intermittent versus continuous infusion against Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model. (Q35136776) (← links)
- Pharmacokinetics of 1-(2-fluoro-5-methyl-beta-L-arabinofuranosyl)uracil in woodchucks (Q35138496) (← links)
- Pharmacodynamics of vancomycin alone and in combination with gentamicin at various dosing intervals against methicillin-resistant Staphylococcus aureus-infected fibrin-platelet clots in an in vitro infection model. (Q35138989) (← links)
- Multiple-dose pharmacokinetics of oral zidovudine in hemophilia patients with human immunodeficiency virus infection (Q35249948) (← links)
- Vancomycin pharmacokinetics in burn patients and intravenous drug abusers (Q35253581) (← links)
- Pharmacokinetics of 3'-fluoro-3'-deoxythymidine and 3'-deoxy-2',3'-didehydrothymidine in rhesus monkeys (Q35262604) (← links)
- Safety and pharmacokinetics of rimantadine small-particle aerosol (Q35282312) (← links)
- Pharmacokinetics of two multiple-dose mezlocillin regimens (Q35306618) (← links)
- Phase I trial of 17-allylamino-17-demethoxygeldanamycin in patients with advanced cancer (Q35469572) (← links)
- Pharmacokinetics of amikacin in serum and in tissue contiguous with pressure sores in humans with spinal cord injury (Q35565358) (← links)
- Pharmacokinetics of aztreonam in patients with gram-negative infections (Q35568767) (← links)
- Pharmacokinetics and pharmacodynamics of granulocyte-macrophage colony-stimulating factor and zidovudine in patients with AIDS and severe AIDS-related complex (Q35810392) (← links)
- Pharmacokinetics and bactericidal rates of daptomycin and vancomycin in intravenous drug abusers being treated for gram-positive endocarditis and bacteremia (Q35836523) (← links)
- Pharmacokinetics, plasma protein binding and urinary excretion of N omega-nitro-L-arginine in rats (Q35874212) (← links)
- Pharmacokinetics and tolerability of oral rizatriptan in healthy male and female volunteers (Q36053366) (← links)
- A phase I trial of docetaxel and pulse-dose 17-allylamino-17-demethoxygeldanamycin in adult patients with solid tumors. (Q36316817) (← links)
- A multi-center phase Ib study of oxaliplatin (NSC#266046) in combination with fluorouracil and leucovorin in pediatric patients with advanced solid tumors (Q36467960) (← links)
- Liquid chromatography-mass spectrometric assay for quantitation of the short-chain fatty acid, 2,2-dimethylbutyrate (NSC 741804), in rat plasma (Q36478403) (← links)